Article
Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.
Antimicrobial agents and chemotherapy - 1 Dec 2016
Hays Constantin, Louis Mathilde, Plainvert Céline, Dmytruk Nicolas, Touak Gérald, Trieu-Cuot Patrick, Poyart Claire, Tazi Asmaa
Abstract excerpt
Group B Streptococcus (GBS) is the leading cause of neonatal invasive infections and an emerging pathogen in the elderly. Our objectives were to describe the evolution of GBS resistance to antibiotics in France and to investigate the emergence of fluoroquinolone (FQ)-resistant isolates. A total of 8,757 unrelated GBS isolates were collected and tested for antibiotic susceptibility from 2007 to 2014 according to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
